This report provides an overview of the cases of hepatitis of unknown origin in children aged 16 years and below reported to ECDC and the WHO Regional Office for Europe through The European Surveillance System (TESSy).
The European Centre for Disease Prevention and Control (ECDC) and the European Food Safety Authority (EFSA) kindly invite you to join a webinar on West Nile virus and Usutu virus infections among humans and animals, with a focus on the situation in the European Union.
The fifth meeting of the Hepatitis B and C Network aims to bring together experts from across the EU to discuss how Europe can improve its response to the epidemics of hepatitis B and C with a focus on surveillance, estimating prevalence, and the monitoring of response.
The European public health and blood authorities responded to the threat posed by West Nile virus to blood safety of blood and blood components by adopting preventive measures which are defined in the EU blood legislation, professional guides of the Council of Europe and the EU WNV blood transfusion preparedness plan. The measures include the deferral of blood donors that have visited or residing in a NUTS 3 area considered to be affected (i.e. with at least one confirmed case).
The key objective of this meeting was to verify the rationale and objectives of molecular typing for surveillance of hepatitis E virus (HEV) through the hepatitis E network (HEVnet). The workshop reviewed HEVnet as a tool for molecular surveillance of HEV in Europe.
The conference addressed long-term effectiveness HIV of drugs, co-infections with tuberculosis or viral hepatitis and other co-morbidities, and most inequitable access to care across Europe